1. Volume 150, Issue 1, Pages 27-34 (July 2016)
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System 
Robert C. Bourge, MD, Aaron B. Waxman, MD, PhD, Mardi Gomberg-Maitland, MD, Shelley M. Shapiro, MD, PhD, James H. Tarver, MD, Dianne L. Zwicke, MD, Jeremy P. Feldman, MD, Murali M. Chakinala, MD, Robert P. Frantz, MD, Fernando Torres, MD, Jeffrey Cerkvenik, MS, Marty Morris, MS, Melissa Thalin, RN, BSN, MBA, Leigh Peterson, PhD, Lewis J. Rubin, MD 
CHEST 
Volume 150, Issue 1, Pages (July 2016)
DOI: /j.chest
Copyright © 2016 The Authors Terms and Conditions

2. Figure 1 Implantation location of the drug delivery system.
CHEST  , 27-34DOI: ( /j.chest )
Copyright © 2016 The Authors Terms and Conditions

3. Figure 2
Plasma treprostinil levels at baseline and 1 week postimplantation (r = 0.91; P < .0001).
CHEST  , 27-34DOI: ( /j.chest )
Copyright © 2016 The Authors Terms and Conditions